Literature DB >> 6306161

Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.

J C de Jong, R Wigand, A H Kidd, G Wadell, J G Kapsenberg, C J Muzerie, A G Wermenbol, R G Firtzlaff.   

Abstract

About 200 antigenically related adenoviruses were isolated from cases of infantile diarrhoea in the Netherlands and North-West Germany. The viruses were fastidious and failed to replicate serially in human diploid fibroblasts and in primary human embryonic kidney cells. A number of strains were established in HeLa, HEp-2, Graham (293), cynomolgus monkey kidney, and Chang conjunctival cells. The viruses were mammalian adenoviruses by the usual criteria. No relationship to the 39 known human adenovirus species was found, either by neutralization tests or by haemagglutination inhibition tests. Neutralization tests showed two distinct variants, represented by strains Tak and Dugan. The variants were identical in haemagglutination inhibition tests. DNA restriction enzyme analysis showed Tak and Dugan to have considerably different genomes, indicating that these variants should be classified as different species (Wadell et al, 1983). It is proposed that the variants should be called Mastadenovirus h 40 (with reference strains Dugan and Hovi X) and Mastadenovirus h 41 (with reference strain Tak). Neutralization and haemagglutination inhibition tests demonstrated that the viruses from Glasgow and Helsinki (Hovi X) described by Johansson et al [1980] and by Kidd and Madeley [1981] belong to these two adenovirus species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306161     DOI: 10.1002/jmv.1890110305

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  89 in total

1.  Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis.

Authors:  A Allard; B Albinsson; G Wadell
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  PCR and restriction endonuclease analysis for rapid identification of human adenovirus subgenera.

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Effect of host cells on low- and medium-pressure UV inactivation of adenoviruses.

Authors:  Huiling Guo; Xiaona Chu; Jiangyong Hu
Journal:  Appl Environ Microbiol       Date:  2010-09-17       Impact factor: 4.792

4.  Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata, India.

Authors:  Rakhi Sharma Dey; Santanu Ghosh; Mamta Chawla-Sarkar; Sandra Panchalingam; James P Nataro; Dipika Sur; Byomkesh Manna; Thandavarayan Ramamurthy
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

5.  DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens.

Authors:  G Hammond; C Hannan; T Yeh; K Fischer; G Mauthe; S E Straus
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

6.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

7.  Human adenovirus type 52: a type 41 in disguise?

Authors:  J C de Jong; A D M E Osterhaus; Morris S Jones; Balázs Harrach
Journal:  J Virol       Date:  2008-04       Impact factor: 5.103

8.  Development and Evaluation of a Loop-Mediated Isothermal Amplification Assay for the Detection of Adenovirus 40 and 41.

Authors:  P G Ziros; P A Kokkinos; A Allard; A Vantarakis
Journal:  Food Environ Virol       Date:  2015-02-04       Impact factor: 2.778

9.  Specific properties of two enteric adenovirus 41 clones mapped within early region 1A.

Authors:  A K Allard; G Wadell; K M Evander; G K Lindman
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

10.  Cloning and physical mapping of enteric adenoviruses (candidate types 40 and 41).

Authors:  H E Takiff; W Reinhold; C F Garon; S E Straus
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.